학술논문
The Ratio of Plasma Amyloid-β 1-42 over Serum Albumin Can Be a Novel Biomarker Signature for Diagnosing End-Stage Renal Disease-Associated Cognitive Impairment
Document Type
Article
Author
Source
In: Journal of Alzheimer's Disease . (Journal of Alzheimer's Disease, 30 January 2024, 97(3):1393-1405)
Subject
Language
English
ISSN
18758908
13872877
13872877